A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist treatment and points to potential new combination therapies to make treatments more effective.
The research,…
Discovery reveals role of EGFR in resistance to KRAS inhibitors in pancreatic cancer
